Wang Xiaolin 4
4 · Revolution Medicines, Inc. · Filed Dec 21, 2022
Insider Transaction Report
Form 4
Wang Xiaolin
See Remarks
Transactions
- Sale
Common Stock
2022-12-19$22.94/sh−708$16,241→ 30,527 total
Footnotes (3)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units ("RSUs") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes.
- [F2]This transaction was executed in multiple trades in prices ranging from $22.4706 to $22.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 22,550 RSUs.